Bumrungrad International Hospital
Recommended Vaccines for and Older Adults Adults
Recommended Vaccines for Adults Vaccine 19-26 Years
27-49 Yea
1 Time/Year
COVID – 19
Influenza
Tdap once
Tetanus, diphtheria, pertussis (Tdap or Td)
1 or 2 doses depending
Mumps, Measles, Rubella (MMR)
2 Times
Varicella (VAR)
2 doses for individuals with immunocompromised con
Zoster
2 or 3 doses depending on the age at vaccination.
3 Times (age 27-4
Human Papillomavirus Virus (HPV)
Click for more info
Pneumococcal (PCV 13, PCV 15, PPSV 23 )
3 Times (age ≤ 59 years)
Hepatitis B (Hep B)
Dengue Virus
Pregnant at 32 – 36 weeks
Respiratory Syncytial Virus
Recommended Vaccines for Adults.
Recommended vaccin additional risk factors
ars
50-64 Years
≥65 Years
1 Time/Year (age ≥ 60 years)
1 Time/Year
e, then Td or Tdap booster every 10 years.
g on indication.
2 Times
2 Times (age ≥ 50 years)
nditions.
45 years)
(age ≥ 65 years)
ormation
3 Times
2 Times (age ≥ 4 years)
1 Time (age 60-74 years)
1 Time (age ≥ 75 years)
nes for adults with or other indications.
Vaccines recommended based on a physician’s assessment.
COVID
What is an mRNA vaccine? An mRNA vaccine is produced using synthetic genetic material that mimics the genetic code of the virus. When injected into the body, it instructs cells to produce spike proteins, which then stimulate the immune system to build immunity against the SARS-CoV-2 virus, without harming human cells. Currently, there is one mRNA vaccine available in Thailand: COMIRNATY™.
Who should receive the COVID-19 vaccine?
Group 1: High-risk individuals — People aged 60 years and older, or those with chronic illnesses such as chronic respiratory diseases, cardiovascular disease, chronic kidney failure, stroke, obesity, cancer, diabetes, or pregnant women should receive an annual COVID-19 vaccine. Group 2: Those at risk of exposure or transmission — Such as service workers or those whose jobs involve close contact with many people, and those living or working in crowded places. Group 3: Healthcare workers.
Why is it get vacci • Updated COVID-1 against currently c continues to evolv • Immunity from pa over time. • High-risk groups re and death. • It helps reduce the complications afte
We recommend receiving the COVID-19 vaccine annually.
Following a COVID-19 infection, vaccination should be administered
no sooner than three months after infection.
D – 19
Side effects
COVID-19 vaccines may cause mild side effects similar to other vaccines, such as: Pain or swelling at the injection site Muscle aches Chills Fever.
Who should not receive the vaccine?
• Individuals who have had a severe allergic reaction to a COVID-19 vaccine or its components. • Those who have a fever or are currently ill should postpone vaccination. (Those with mild cold symptoms and no fever may still receive the vaccine.)
Efficacy and protection from COVID-19 vaccination:
necessary to inated annually? 19 vaccines are designed to protect circulating variants, as the virus ve. ast vaccination or infection wanes
71 % 73 % 60 %
Reduces hospitalization rate by
emain at risk of severe illness
Reduces severity rate by
e risk of developing long-term er COVID-19 (Long COVID).
Reduces death rate by
In uenz
Influenza (Flu) Vaccine
What does the flu vaccine contain? A Effectiveness:
in uenza 4
2 The quadrivalent flu vaccine contains: strains of Influenza
B
2 strains of Influenza
40 % – 60 % The vaccine can prevent flu illness in Those who get the flu after vaccination usually experience less severe symptoms. of cases.
Who should get the flu vaccine? Everyone aged 6 months and older is recommended to receive the flu vaccine annually, especially people at high risk of severe illness:
*Enhance For seniors is available is 4 times t immune re older adul Clinical fin vaccines in • 24.2% inc • 27.3% red • 17.9% red and respi • 11.7% red • 8.4% redu
60 4 containing micrograms of antigen, which is
Pregnant women
Young children aged 6 months to 2 years
(4 months gestation and above)
or have a BMI over 35 kg/m² Individuals who weigh over 100 kg
65 years and older* Seniors aged
times
People with chronic illnesses such as: Chronic obstructive pulmonary disease (COPD), Asthma, Heart disease, Kidney failure, Stroke, Diabetes, Thalassemia, Cancer patients undergoing chemotherapy, Individuals with neurological disabilities who cannot care for themselves, Immunocompromised persons, People living with HIV
za (Flu)
Once a year
The flu vaccine is updated annually to match the strains predicted to be prevalent, based on World Health Organization (WHO) recommendations.
Vaccine
What is the Influenza Virus? The influenza virus is a common cause of acute respiratory infections affecting all age groups. Symptoms may include: Runny nose, Cough, Sore throat, High fever, Headache, Fatigue, Muscle aches In some cases, serious complications may occur, such as pneumonia, encephalitis, or myocarditis, which can be life-threatening. Vaccination is an effective way to prevent influenza.
Possible side effects after flu vaccination Pain, swelling,
ed-dose vaccine for seniors (65+) s aged 65 and older, a high-dose flu vaccine e, containing 60 micrograms of antigen, which the standard dose. This formulation boosts the esponse and provides better protection for lts. ndings comparing high-dose vs. standard flu n adults aged 65+ show: crease in flu prevention duction in hospitalization due to pneumonia duction in hospitalization due to cardiovascular iratory diseases duction in hospitalization due to influenza uction in overall hospitalization
or redness at the injection site Muscle aches Mild fever
Diphthe Teta
What is the Diphtheria–Tetanus–Pertussis Combination Vaccine? This is an inactivated vaccine. In Thailand, there are two main types of combination vaccines for diphtheria, tetanus, and pertussis used across different age groups: DTaP or DTwP vaccine: Used for infants and children under 7 years of age. Tdap vaccine: Used for children aged 4 and up through adulthood. The lowercase letters “d” and “p” indicate reduced
1 2
amounts of diphtheria toxoid and pertussis antigens to reduce potential side effects.
The letter “a” in DTaP and Tdap stands for “acellular”, meaning only certain parts of the pertussis bacterium are used instead of the whole-cell version (which is used in DTwP). This helps reduce adverse reactions. There is also a Td vaccine, which protects only against diphtheria and tetanus (not pertussis) and is suitable for individuals who cannot receive pertussis-containing vaccines.
Understanding the Dis Diphtheria (D): Caused by the Corynebac which produces a toxin that leads to thick memb This can cause airway obstruction, muscle paraly even be fatal despite treatment. Tetanus (T): A life-threatening disease caus Clostridium tetani bacterium, leading to severe m the body. It can cause “lockjaw,” where the patien swallow, or breathe. Pertussis (P) / Whooping Cough infection caused by bacteria that results in severe
eria, anus, and
This vaccine is part of the national immunization schedule in Thailand for all children. Who Should Get the Diphtheria–Tetanus– Pertussis Vaccine?
Pertussis (Whooping Cough) Vaccine
4 doses (DTaP or DTwP) 2, 4, 6, and 18 months at 1 dose (DTaP, DTwP, or Tdap) age 4–6 years at
Infants
Young children
Booster Dose Recommendations:
Ages 11–18 years: One doe of Tdap, preferably between ages 11-12. Age 19 and older: Anyone who has never received Tdap, or is in close contact with infants under 12 months, should receive 1 dose of Tdap Pregnant women: 1 dose of Tdap should be administered between 27–36 weeks of gestation. It can be given at any point during pregnancy if needed. This also helps transfer immunity to the unborn baby. Note: Tdap or Td booster doses are recommended every 10 years throughout life, as immunity does not last a lifetime.
seases:
cterium diphtheriae bacterium, branes forming in the throat. ysis, heart failure, and may
sed by a toxin from the muscle spasms throughout nt cannot open their mouth,
Side Effects After Tdap Vaccination:
h: A contagious respiratory e, uncontrollable coughing fits.
Side effects are usually mild and short-lived. Common side effects include: Pain, redness, or swelling at the injection site, Low-grade fever, Headache and Fatigue.
Mea Mum Rubella (MM
What is the MMR Vaccine? The MMR vaccine is a combination vaccine containing live attenuated viruses of mumps, measles, and rubella. It is recommended for both children and adults. In Thailand, the Pediatric Infectious Disease Society classi es it as a mandatory vaccine for all children. of the Mumps, Measles, and Rubella (MMR) vaccine? What are the side effects Common side effects include fever (usually occurring within 6–12 days after vaccination), skin rash, allergic reactions, or joint inflammation.
What Are Measles, Mumps, and Rubella?
Viral Disease
Symptoms
Fever, headache, muscle aches, loss of appetite, and swelling of salivary glands (usually within 48 hours)
Mumps
Fever, cough, conjunctivitis, runny nose, and red rash that typically begins on the face and spreads downward (within 48 hours)
Measles
In
Fever, swollen lymph nodes, and rash that usually appears 1–5 days later. More common in children than adults
Rubella
Vaccine asles, mps, and MR)
Who Should Receive
the MMR Vaccine?
Children:
Recommended in 2 doses:1st dose: at 12–15 months2nd dose: at 4–6 years In the case of an outbreak, the first dose can be given at 6 months, followed by additional doses at 12 months and 2.5 years as per schedule. Those who have never received the vaccine or are unsure of their vaccination history should get 2 doses at least 28 days apart. Women planning pregnancy and without prior vaccination history should receive 1 dose at least 1 month before becoming pregnant.
Adults:
Who Should NOT Receive the MMR Vaccine? • Anyone with a history of severe allergic reactions to MMR vaccines. • Pregnant women. • Immunocompromised individuals • Those who have received a blood transfusion or blood products within the past 3–11 months, as this may affect the vaccine’s effectiveness. • Individuals who are severely ill. • People with a history of anaphylaxis to neomycin.
Complications
Inflammation of the testicles, ovaries, or meninges (lining of the brain and spinal cord)
Severe complications such as pneumonia, encephalitis, and in rare cases, blindness or death. Higher risk in adults over 20 years old
n pregnant women, infection can lead to miscarriage or congenital rubella syndrome, causing birth defects such as heart disease, liver problems, and neurological disorders like deafness or brain inflammation
Varic
It is a live attenuated vaccine prepared from a weakened form of the varicella-zoster virus. What is the chickenpox vaccine? two full doses of the vaccine Receiving o ers high e ectiveness in preventing infection and reducing disease severity. However, vaccinated individuals may still contract chickenpox, but the symptoms are typically milder and recovery is faster than in unvaccinated individuals.
Chickenpox (Varicella) is a highly contagious disease caused by the varicella-zoster virus (VZV). It leads to an itchy rash with fluid-filled blisters, typically starting on the chest, back, and face, before spreading to other parts of the body. Other common symptoms include fever, fatigue, loss of appetite, and headache. Possible complications of chickenpox include skin infections, pneumonia, vasculitis (inflammation of blood vessels), encephalitis (inflammation of the brain), and sepsis (bloodstream infection). In addition, individuals who have previously had chickenpox may later develop shingles (Herpes zoster). What is chickenpox?
Since the fluid-filled blisters of chickenpo contain the varicella virus, the disease is typically transmitted through:
Inhalation of aerosolized pa from the blisters Direct contact with the bliste ouching objects contaminat with the virus
Vaccination is recommended for everyon Those who receive 2 full doses typically develop lifelong immunity.
cella
Anyone who has never had chickenpox and has not been vaccinated should receive the vaccine as follows: (Additional vaccine schedule would typically follow here.) 1-12 the chickenpox vaccine? Who should receive years Number of Doses: 2 doses
(Chickenpox)
Vaccine
Dose 1: at age 12–15 months Dose 2: at age 18 months to 4 years
13
years and older
Number of Doses: 2 doses
At least 28 days apart
Who should NOT receive the chickenpox vaccine?
Pregnant women or those planning to become pregnant within the next 3 months
ox
Individuals with weakened immune systems, patients with active tuberculosis who are not receiving treatment, or those currently experiencing a fever
Individuals taking immunosuppressive medications
articles
Those who have recently received a blood transfusion or other blood products
ers ted
What are the possible side effects of the chickenpox vaccine? Common side effects include pain, swelling, or redness at the injection site, and fever (which may occur within 5–12 days after vaccination).
ne.
Shi
What is
the shingles vaccine?
There are two types of shingles vaccines:
Live attenuated vaccine: Prevents shingles in adults aged 50–59 years with 69.8% effectiveness. Reduces the risk of postherpetic neuralgia (nerve pain) by 66.5% Recombinant glycoprotein subunit vaccine (non-live): Prevents shingles in adults aged 50 and older with 97.2% effectiveness. Reduces the risk of postherpetic neuralgia by 91.2%
(Herpes zoster or shingles) Shingles
It is a disease caused by the varicella-zoster virus, the same virus that causes chickenpox. After recovering
from chickenpox, the virus remains dormant in the nerve ganglia. When the immune system weakens, it may trigger the reactivation of the varicella-zoster virus, leading to the development of shingles.
Main symptoms of shingles include:
persistent nerve pain th healed. The pain usually months, but in some pa significantly affecting th A common of shingles neuralgia (
Pain or burning sensation on the skin
red rash or clusters of fluid-filled blisters
fever, chills, upset stomach
headache
ingles Vaccine
Everyone aged 50 and older should receive the shingles vaccine, even if they have never had chickenpox. This is because advancing age increases the risk of developing shingles and its potential complications. the shingles vaccine? Who should get
Individuals aged 19 years and older with immunocompromised conditions who are at risk of developing shingles.
You may consult with the hospital’s specialist before receiving the vaccine, as this vaccine has certain limitations for specific groups of people.
Administration of the Shingles Vaccine
Given as a single subcutaneous injection Live attenuated vaccine: Recombinant glycoprotein subunit vaccine (non-live): Given as two intramuscular injections, with the second dose administered 2–6 months after the first dose
hat remains even after the rash has y improves gradually over weeks or atients, it may last for years, heir quality of life. n complication s is postherpetic (PHN) —
What are the possible side effects after receiving the shingles vaccine?
The most common side effects after vaccination include pain or swelling at the injection site.
Huma papillom
9
What is the
-valent HPV vaccine?
The Human Papillomavirus 9-valent vaccine is an inactivated (non-live) vaccine.
Used to protect against infection with 9 types of HPV: types
6 11 16 18
31
33 45 52 58
in both females and males aged 9 to 45 years.
What diseases can this vaccine help prevent?
caused by HPV types 16, 18, 31, 33, 45, 52, and 58
caused
Cervical cancer
vulvar cancer
vaginal cancer
anal cancer
cancers of the mouth and throat
an mavirus Vaccine
HPV, or Human Papillomavirus, is a virus with over 200 different strains. It is divided into two groups: What is the HPV virus?
High Risk HPV
Includes 14 strains: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. which can cause cancer of genital area and anus.
Low Risk HPV
Includes strains 6 and 11, which can cause genital warts — a sexually transmitted disease.
Genital warts (condyloma acuminata) caused by HPV types 6 and 11
by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58
Precancerous lesions of the cervix
vulva
vagina
anus
วัคซีน Hu papillom
How is this vaccine administered? The number of vaccine doses depends on the age at the time of vaccination, as shown in the table. Age Range
9-14
years*
Dose 1: On the desired vaccination date Dose 2: 5–13 months after the first dose Vaccination Schedule Number of Doses: 2 doses**
Number of Doses: 3 doses**
Dose 1: On the desired vaccination date Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose * The doctor will determine the appropriate number of vaccine doses to be administered. ** If the second dose is given less than 5 months after the rst dose, a third dose is required. Vaccination Schedule
15-45 Age Range years*
Yes, the 9-valent HPV vaccine can It is recommended to wait approx the last dose of the 2-valent or 4-v starting the 9-valent series. The fu completed. However, the necessit of this additional vaccination shou If I have already compl or 4-valent HPV vaccin get the 9-valent HPV v
3 doses
Vaccination Schedule
Dose 1: On the desired vaccination date Dose 2: 2 months after the first dose Dose 3: 6 months after the first dose
uman mavirus
Common Side Effects of This Vaccine
In general, serious side effects are rare. Mild side effects may occur, such as pain, swelling, or redness at the injection site, headache, fever, nausea, dizziness, or fatigue. These symptoms are temporary and usually resolve on their own. This vaccine should not be administered to individuals who have had an allergic reaction after receiving the 9-valent or 4-valent HPV vaccine previously, or who are allergic to any component of the vaccine, including those with a severe yeast allergy. Contraindications for This Vaccine
Additionally, the 9-valent HPV vaccine is not recommended for pregnant women. If a dose has not yet been completed, vaccination should be postponed and resumed after childbirth to complete the full 3-dose series. However, the 9-valent HPV vaccine can be given to breastfeeding women.
n still be administered. ximately one year after leted the 2-valent ne series, can I still vaccine? valent HPV vaccine before ull 3-dose series must be ty and appropriateness uld be assessed by your doctor.
There are two types of pneumococcal vaccines available in Thailand, each covering di erent serotypes of the bacteria: Pneumococcal Vaccines
Pneumo Conju Vaccine
1 2
Pneumococcal Conjugate Vaccine (PCV): PCV13 covers 13 serotypes PCV15 covers 15 serotypes PCV20 covers 20 serotypes
Covers 23 serotypes Pneumococcal Polysaccharide Vaccine (PPSV23)
Understanding Pneumococcal Disease Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae (S. pneumoniae). It can lead to various infections such as: Middle ear infection Sinus infection Pneumonia (lung infection)Bloodstream infection (sepsis) Meningitis (infection of the membranes around the brain and spinal cord) These conditions can lead to serious complications or even death. Fortunately, pneumococcal infection is preventable through vaccination.
How Many Doses Are Needed?
For children:
Divided into 2 gro For adults
PCV13, PCV15, or PCV20 should be given at ages 2, 4, 6 months, and a booster at 12–15 months (A total of 4 doses)
Group 1:
Adults aged 18–64 years (as shown in Table
ococcal ugate (PCV)
Table 1: Recommendations for Pneumococcal Vaccination (Ages 18–64)
Guidelines for Pneumococcal Vaccination
Group
Option 2
Option 1
No underlying conditions or risk factors
Patients with the following risk factors: • Chronic alcoholism • Chronic heart disease • Chronic lung disease • Chronic liver disease • Diabetes mellitus • Smoking Patients with the following risk factors: • Have undergone cochlear implant surgery • Have cerebrospinal fluid (CSF) leaks Immunocompromised patients with the following risk factors: • Chronic kidney disease • Asplenia or impaired splenic function • Congenital or acquired immunodeficiency • General malignancies
PCV20 PCV13 PCV15 or
≥1 year: Consider
PPSV23
PCV20 PCV13 PCV15 or
≥8 weeks
PPSV23
PCV20 PCV13 PCV15 or
(solid tumors) • HIV infection
≥8 weeks
• Hodgkin lymphoma • Complications from immunosuppressive medications • Leukemia • Lymphoma • Multiple myeloma or myeloid leukemia • Nephrotic syndrome • Sickle cell disease or other hemoglobinopathies • Organ transplantation
s:
PPSV23
≥5 years
oups:
PPSV23
Group 2: Adults aged 65 years and older (as shown in Table 2)
e 1)
Pneumococcal Conjugate (PCV) Vaccine
What are the possible side effects after receiving the pneumococcal vaccine ? Most side effects are mild and may include redness, swelling, pain, or tightness at the injection site. Some individuals may also experience fatigue, fever, headaches, or muscle aches. These symptoms usually resolve on their own within 2–3 days.
Table 2: Adults aged 65 years and above
Guidelines for Pneumococcal Vaccination
Group
Option 1
Option 2
Aged 65 years and above
PCV20
PCV13 PCV15 or
≥1 year: Consider
PPSV23
Adults aged 65 and above with immunocompromised conditions, cochlear implants, or cerebrospinaluid leaks
PCV20
PCV13 PCV15 or
≥8 weeks
PPSV23
If you have previously received PCV13 , PCV15 and/or PPSV23 and wish to enhance immunity against additional serotypes, please consult your physician to consider receiving PCV20 .
Hepa B
Hepatitis B Vaccine
The hepatitis B vaccine contains a surface protein of the virus (HBsAg), which does not cause infection but stimulates the body to develop immunity. It can be administered from birth, using
the same 3-dose schedule as adults. After the rst dose, the second dose is given 1 month later, and the third dose 6 months after the rst dose.
1
2
1 month
3
6 months
After completing all 3 doses, the vaccine can induce immunity in approximately 80 % - 100 % of individuals, providing long-term protection —often lifelong. However, it is recommended to undergo a blood test 1–2 months after the nal dose to con rm immunity. If protective antibodies are not present, additional doses may be advised by a physician.
Hepatitis B is a serious v it can lead to chronic liv liver cancer. It can be tra (from mother to child), or open wounds, Sexua person, Sharing needle such as razors or toothb Hepatitis
atitis
• Newborns and children • Individuals who do not have immunity to hepatitis B Who Should Get the Hepatitis B Vaccine?
B Vaccine
• Close contacts of hepatitis B carriers • Healthcare workers and hospital staff • Patients with chronic liver disease
• Chronic kidney disease patients undergoing dialysis • Individuals receiving frequent blood transfusions • People who use injectable narcotic drugs • Travelers to areas with high hepatitis B prevalence • Individuals at risk due to sexual behavior (e.g., multiple partners)
Side Effects Possible
Mild side e ects may include low-grade fever, pain, redness, or swelling at the injection site, which typically resolve within 1–2 days.
viral infection. Without treatment, ver inflammation, cirrhosis, or ansmitted through: Childbirth Contact with infected blood al contact with an infected es or personal items brushes. s B Virus (HBV)
Deng Vaccine
What is
Dengue Fever?
Dengue fever is caused by dengue viruses and is transmitted from person to person through the bite of an infected Aedes mosquito. More than 70% of those at risk of infection live in Southeast Asia and the Western Paci c region. There are 4 serotypes of the dengue virus: During outbreaks, all four types can circulate simultaneously. Therefore, one person can be infected with more than one serotype over time, and it is possible to contract dengue more than once. DENV-1 DENV-2 DENV-3 DENV-4
What are the symptoms of dengue fever?
In addition to high fever, patients may also experience
Severe headache
Pain behind the eyes
They may also have: Muscle and joint pain
4-10
2-7
infection. days after
These symptoms usually appear
Which can last for another
days
Although many cases (about 1 in 4) present with only mild symptoms, children and individuals with a second dengue infection are at risk of developing severe illness such as: Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS)
Warning signs of severe dengue usually occur as the fever subsides, including: Severe abdominal pain or tenderness, vomiting at least 3 times within 24 hours
Early diagnosis and proper medical treatment are crucial in reducing the risk of severe complications and death.
Nosebleeds or bleeding gums, vomiting blood or passing blood in the stool, fatigue, restlessness, or irritability
gue
Understanding the Dengue Vaccine
Currently, Thailand offers a live attenuated dengue vaccine which provides protection against all four dengue virus serotypes.
This vaccine uses Dengue serotype 2 virus backbone (DEN-2) and is recommended as a 2-dose schedule, with the second dose given 3 months after the rst. regardless of prior dengue infection history. No laboratory confirmation of past infection is required. It is suitable for people aged 4 years and older, 80 % protection against dengue infection 90 %
Vaccine E ectiveness: Provides up to
Reduces risk of severe dengue requiring hospitalization by up to
Based on a 10-year follow-up study, no booster dose is currently needed. However, since the vaccine does not offer complete protection, mosquito bite prevention remains essential.
Side effects are generally mild and short-term, lasting only a few days. They may include: Pain, itching, or soreness at the injection site , headaches, fatigue. As with any vaccine, there is a possibility of allergic reactions or adverse events, which should be monitored carefully. Possible Side Effects
RS
What is RSV?
Pneum
RSV, or Respiratory Syncytial Virus, is a highly contagious virus that can severely a ect the respiratory system. There are two types of RSV:
RSV- A
RSV- B
and
What are the symptoms of RSV infection?
Symptoms typically appear 2–8 days after exposure, and may resemble the common cold, including: fever, cough, sneezing, nasal congestion, runny nose. If the infection progresses to the lower respiratory tract, it can cause complications such as: Bronchiolitis and Pneumonia. In severe cases, patients may experience: rapid breathing or difficulty breathing, wheezing, bluish skin discoloration. These symptoms may require urgent hospitalization and can be life-threatening.
Administered as a injection (1 do No booster requir at this time. Vaccine E ectiven RSV-related lower infections with 80 e ectiveness. How is the va administ
Who should receive the RSV vaccine?
with chronic medical conditions such as: Diabetes, Heart disease, Kidney disease, Lung disease Adults aged 50 and above
60 and older Adults aged
Pregnant women
at gestational age between 32 and 36 weeks
SV
Benefits of the RSV Vaccine
monia Vaccine
• Stimulates the immune system to build protection against RSV • Reduces the risk of infection in older adults. Lessens severity of symptoms such as cough, breathing difficulties, and pneumonia. • Prevents serious complications including: Pneumonia, Bronchiolitis, Chronic obstructive pulmonary disease (COPD), Heart failure. • Lowers the risk of death from RSV, especially in high-risk individuals
Types of RSV Vaccines
Available in Thailand
1 2
Single-strain
protein-based vaccine:
Contains RSV subtype A + an adjuvant (immune booster)
protein-based vaccine:
Dual-strain
accine tered?
Contains both RSV subtype A and B. Approved for use in pregnant women (24–36 weeks) to pass immunity to the fetus.
a single intramuscular ose). red
Possible Side Effects
ness that prevents r respiratory tract 0–90%
Common, mild side effects similar to other vaccines include: fatigue, headaches, muscle pain. Symptoms are typically mild and resolve on their own within 1–2 days.
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29Powered by FlippingBook